Moreover, the current diagnostic techniques are insufficient to screen out early asymptomatic patients, and the serum tumor markers of PDAC, such as carbohydrate antigen 19-9 (CA19-9) and carcinoembryonic antigen (CEA), have limited specificity and sensitivity. The gene discussed is CEACAM5; the disease is neoplasm.